NCT00404300 - Optivate in People With Von Willebrand Disease Undergoing Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

September 30, 2008

Conditions

Von Willebrand Disease

Interventions

DRUG

Optivate

Plasma-derived Factor VIII

Trial Locations (4)

Rambam Health Care Campus, 8 Haaliya St., Bat-Galim, Haifa

Beilinson Hospital, Rabin Medical Center, 39 Jabotinsky Street, Petah Tikva

Haddasah Ein-Karem Medical Center, P.O.Box 12000, Jerusalem

Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, London